|
LAXATIVES MAY INTERFERE WITH THE ABSORPTION OF THE DRUGS
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
POTENTIAL FOR INCREASED RISK OF HYPERCALCEMIA ; CONCURRENT USE WITH OTHER CALCIUM SUPPLEMENTS IS NOT RECOMMENDED
|
POTENTIAL FOR INCREASED RISK OF HYPERCALCEMIA ; CONCURRENT USE WITH OTHER CALCIUM SUPPLEMENTS IS NOT RECOMMENDED
|
POTENTIAL FOR INCREASED RISK OF HYPERCALCEMIA ; CONCURRENT USE WITH OTHER CALCIUM SUPPLEMENTS IS NOT RECOMMENDED
|
POTENTIAL FOR INCREASED RISK OF HYPERCALCEMIA ; CONCURRENT USE WITH OTHER CALCIUM SUPPLEMENTS IS NOT RECOMMENDED
|
POTENTIAL FOR INCREASED RISK OF HYPERCALCEMIA ; CONCURRENT USE WITH OTHER CALCIUM SUPPLEMENTS IS NOT RECOMMENDED
|
POTENTIAL FOR INCREASED RISK OF HYPERCALCEMIA ; CONCURRENT USE WITH OTHER CALCIUM SUPPLEMENTS IS NOT RECOMMENDED
|
POTENTIAL FOR INCREASED RISK OF HYPERCALCEMIA ; CONCURRENT USE WITH OTHER CALCIUM SUPPLEMENTS IS NOT RECOMMENDED
|
POTENTIAL FOR INCREASED RISK OF HYPERCALCEMIA ; CONCURRENT USE WITH OTHER CALCIUM SUPPLEMENTS IS NOT RECOMMENDED
|
POTENTIAL FOR INCREASED RISK OF HYPERCALCEMIA ; CONCURRENT USE WITH OTHER CALCIUM SUPPLEMENTS IS NOT RECOMMENDED
|
POTENTIAL FOR INCREASED RISK OF HYPERCALCEMIA ; CONCURRENT USE WITH OTHER CALCIUM SUPPLEMENTS IS NOT RECOMMENDED
|
POTENTIAL FOR INCREASED RISK OF HYPERCALCEMIA ; CONCURRENT USE WITH OTHER CALCIUM SUPPLEMENTS IS NOT RECOMMENDED
|
POTENTIAL FOR INCREASED RISK OF HYPERCALCEMIA ; CONCURRENT USE WITH OTHER CALCIUM SUPPLEMENTS IS NOT RECOMMENDED
|
POTENTIAL FOR INCREASED RISK OF HYPERCALCEMIA ; CONCURRENT USE WITH OTHER CALCIUM SUPPLEMENTS IS NOT RECOMMENDED
|
POTENTIAL FOR INCREASED RISK OF HYPERCALCEMIA ; CONCURRENT USE WITH OTHER CALCIUM SUPPLEMENTS IS NOT RECOMMENDED
|
VIT D INCREASES CALCIUM ABSORPTION FROM THE GUT
|
VIT D INCREASES CALCIUM ABSORPTION FROM THE GUT
|
POTENTIAL FOR INCREASED RISK OF HYPERCALCEMIA ; CONCURRENT USE WITH OTHER CALCIUM SUPPLEMENTS IS NOT RECOMMENDED
|
POTENTIAL FOR INCREASED RISK OF HYPERCALCEMIA ; CONCURRENT USE WITH OTHER CALCIUM SUPPLEMENTS IS NOT RECOMMENDED
|
POTENTIAL FOR INCREASED RISK OF HYPERCALCEMIA ; CONCURRENT USE WITH OTHER CALCIUM SUPPLEMENTS IS NOT RECOMMENDED
|
POTENTIAL FOR INCREASED RISK OF HYPERCALCEMIA ; CONCURRENT USE WITH OTHER CALCIUM SUPPLEMENTS IS NOT RECOMMENDED
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
VIT D INCREASES CALCIUM ABSORPTION FROM THE GUT
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS MAY CAUSE HYPERCALCAEMIA DUE TO DECREASED CALCIUM EXCRETION
|
VIT D INCREASES CALCIUM ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
POTENTIAL FOR INCREASED RISK OF HYPERCALCEMIA ; CONCURRENT USE WITH OTHER CALCIUM SUPPLEMENTS IS NOT RECOMMENDED
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
POTENTIAL FOR INCREASED RISK OF HYPERCALCEMIA ; CONCURRENT USE WITH OTHER CALCIUM SUPPLEMENTS IS NOT RECOMMENDED
|
THERE IS HIGH RISK OF HYPERCALCEMIA IF DIBASIC CAL PHOSPHATE IS COADMINISTERED WITH THIAZIDE DIURETICS AND CALCIUM
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
THERE IS HIGH RISK OF HYPERCALCEMIA IF IT IS ADMINISTERED WITH THIAZIDE DIURETICS AND CALCIUM
|
DIETARY FIBRE REDUCE ABSORPTION OF THE DRUG FROM THE GUT
|
CALCIUM MAY RAISE SERUM DIGOXIN CONCENTRATION & ENHANCE THE DIGOXIN EFFECT ON HEART LEADING TO DIGOXIN TOXICITY
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM-RICH DRUGS MAY IMPAIR THE ABSORPTION OF ESTRAMUSTINE
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
IRON SALTS INTERFERE WITH THE ABSORPTION OF THE DRUG: HENCE IT SHOULD BE ADMINISTERED 4 HRS BEFORE IRON CONTAINING SALTS
|
IRON SALTS INTERFERE WITH THE ABSORPTION OF THE DRUG: HENCE IT SHOULD BE ADMINISTERED 4 HRS BEFORE IRON CONTAINING SALTS
|
IRON SALTS INTERFERE WITH THE ABSORPTION OF THE DRUG: HENCE IT SHOULD BE ADMINISTERED 4 HRS BEFORE IRON CONTAINING SALTS
|
IRON SALTS INTERFERE WITH THE ABSORPTION OF THE DRUG: HENCE IT SHOULD BE ADMINISTERED 4 HRS BEFORE IRON CONTAINING SALTS
|
IRON SALTS INTERFERE WITH THE ABSORPTION OF THE DRUG: HENCE IT SHOULD BE ADMINISTERED 4 HRS BEFORE IRON CONTAINING SALTS
|
IRON SALTS INTERFERE WITH THE ABSORPTION OF THE DRUG: HENCE IT SHOULD BE ADMINISTERED 4 HRS BEFORE IRON CONTAINING SALTS
|
IRON SALTS ABSORPTION FROM THE GUT IS IMPAIRED BY THE DRUG
|
IRON SALTS INTERFERE WITH THE ABSORPTION OF THE DRUG: HENCE IT SHOULD BE ADMINISTERED 4 HRS BEFORE IRON CONTAINING SALTS
|
IRON SALTS INTERFERE WITH THE ABSORPTION OF THE DRUG: HENCE IT SHOULD BE ADMINISTERED 4 HRS BEFORE IRON CONTAINING SALTS
|
IRON SALTS INTERFERE WITH THE ABSORPTION OF THE DRUG: HENCE IT SHOULD BE ADMINISTERED 4 HRS BEFORE IRON CONTAINING SALTS
|
IRON SALTS INTERFERE WITH THE ABSORPTION OF THE DRUG: HENCE IT SHOULD BE ADMINISTERED 4 HRS BEFORE IRON CONTAINING SALTS
|
IRON SALTS INTERFERE WITH THE ABSORPTION OF THE DRUG: HENCE IT SHOULD BE ADMINISTERED 4 HRS BEFORE IRON CONTAINING SALTS
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
IRON SALTS INTERFERE WITH THE ABSORPTION OF THE DRUG: HENCE IT SHOULD BE ADMINISTERED 4 HRS BEFORE IRON CONTAINING SALTS
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
CALCIUM SALTS MAKE CHELATING AGENTS WITH THE DRUG AND IMPAIR ABSORPTION
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
MAGNESIUM CONTAINING SALTS MAY INTERFERE WITH THE ABSORPTION OF THE DRUG
|
MAGNESIUM CONTAINING SALTS MAY INTERFERE WITH THE ABSORPTION OF THE DRUG
|
MAGNESIUM CONTAINING SALTS MAY INTERFERE WITH THE ABSORPTION OF THE DRUG
|
MAGNESIUM CONTAINING SALTS MAY INTERFERE WITH THE ABSORPTION OF THE DRUG
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
MAGNESIUM CONTAINING SALTS MAY INTERFERE WITH THE ABSORPTION OF THE DRUG
|
MAGNESIUM CONTAINING SALTS MAY INTERFERE WITH THE ABSORPTION OF THE DRUG
|
MAGNESIUM CONTAINING SALTS MAY INTERFERE WITH THE ABSORPTION OF THE DRUG
|
POTENTIAL FOR INCREASED RISK OF HYPERCALCEMIA ; CONCURRENT USE WITH OTHER CALCIUM SUPPLEMENTS IS NOT RECOMMENDED
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
MOLYBDENUM ABSORPTION IS IMPAIRED BY THE DRUG
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
VIT D INCREASES CALCIUM ABSORPTION FROM THE GUT
|
MAGNESIUM CONTAINING SALTS MAY INTERFERE WITH THE ABSORPTION OF THE DRUG
|
IRON SALTS INTERFERE WITH THE ABSORPTION OF THE DRUG: HENCE IT SHOULD BE ADMINISTERED 4 HRS BEFORE IRON CONTAINING SALTS
|
IRON SALTS INTERFERE WITH THE ABSORPTION OF THE DRUG: HENCE IT SHOULD BE ADMINISTERED 4 HRS BEFORE IRON CONTAINING SALTS
|
POTENTIAL FOR INCREASED RISK OF HYPERCALCEMIA ; CONCURRENT USE WITH OTHER CALCIUM SUPPLEMENTS IS NOT RECOMMENDED
|
POTENTIAL FOR INCREASED RISK OF HYPERCALCEMIA ; CONCURRENT USE WITH OTHER CALCIUM SUPPLEMENTS IS NOT RECOMMENDED
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
POTENTIAL FOR INCREASED RISK OF HYPERCALCEMIA ; CONCURRENT USE WITH OTHER CALCIUM SUPPLEMENTS IS NOT RECOMMENDED
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
IRON SALTS INTERFERE WITH THE ABSORPTION OF THE DRUG: HENCE IT SHOULD BE ADMINISTERED 4 HRS BEFORE IRON CONTAINING SALTS
|